Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth F May

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Blood|May 10, 2011
Ex vivo characterization and isolation of rare memory B cells with antigen tetramersBettina Franz, Kenneth F May, Glenn Dranoff, et al.
Cancer Research|June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cellsKenneth F May, Lieping Chen, Pan Zheng, et al.
Blood|April 4, 2002
B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivoXue-Feng Bai, Jinqing Liu, Kenneth F May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2011
Prostate cancer immunotherapyKenneth F May, James L Gulley, Charles G Drake, et al.
Cancer Research|October 3, 2003
On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoiresSupria Sarma, Xue-Feng Bai, Jin-qing Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
B7-deficient autoreactive T cells are highly susceptible to suppression by CD4(+)CD25(+) regulatory T cellsKenneth F May, Xing Chang, Huiming Zhang, et al.
Blood|August 10, 2006
Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing miceKenneth F May, Kenneth Lute, Ergun Kocak, et al.
Cancer Research|November 3, 2004
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2Sameek Roychowdhury, Kenneth F May, Katherine S Tzou, et al.
Blood|July 23, 2005
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodiesKenneth D Lute, Kenneth F May, Ping Lu, et al.
Cancer Research|July 20, 2006
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunityErgun Kocak, Kenneth Lute, Xing Chang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood|May 10, 2011
Ex vivo characterization and isolation of rare memory B cells with antigen tetramersBettina Franz, Kenneth F May, Glenn Dranoff, et al.
Cancer Research|June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cellsKenneth F May, Lieping Chen, Pan Zheng, et al.
Blood|April 4, 2002
B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivoXue-Feng Bai, Jinqing Liu, Kenneth F May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2011
Prostate cancer immunotherapyKenneth F May, James L Gulley, Charles G Drake, et al.
Cancer Research|October 3, 2003
On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoiresSupria Sarma, Xue-Feng Bai, Jin-qing Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
B7-deficient autoreactive T cells are highly susceptible to suppression by CD4(+)CD25(+) regulatory T cellsKenneth F May, Xing Chang, Huiming Zhang, et al.
Blood|August 10, 2006
Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing miceKenneth F May, Kenneth Lute, Ergun Kocak, et al.
Cancer Research|November 3, 2004
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2Sameek Roychowdhury, Kenneth F May, Katherine S Tzou, et al.
Blood|July 23, 2005
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodiesKenneth D Lute, Kenneth F May, Ping Lu, et al.
Cancer Research|July 20, 2006
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunityErgun Kocak, Kenneth Lute, Xing Chang, et al.
Pageof 2